Sound waves open brain barrier to deliver cancer drug in kids
NCT ID NCT07664176
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This early-stage trial tests whether using focused ultrasound with microbubbles can temporarily open the blood-brain barrier, allowing the immunotherapy drug nivolumab to reach brain tumors more effectively. It includes 30 children and young adults with relapsed diffuse midline glioma or other high-grade brain tumors. The main goals are to see if the approach is safe and feasible, not yet to prove it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- nivolumab (an immunotherapy drug) combined with focused ultrasound and microbubbles to open the blood-brain barrier
- What this could lead to
- If it works, this could point toward a way to deliver immunotherapy more effectively to hard-to-treat brain tumors, potentially improving outcomes for children with relapsed diffuse midline glioma.
- What could go wrong
- This is a very early phase 1 safety study with only 30 participants, so it is not designed to prove the treatment works. The procedure carries risks from the ultrasound, microbubbles, and immunotherapy, and may not improve survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could Pre-Surgery proton beams boost brain tumor outcomes?
- Oxygen-Enhanced MRI could sharpen radiotherapy for deadly brain cancers
- Experimental drug combo targets tough brain cancers
- Virus and radiation combo takes on childhood brain cancer
- Supercharged immune cells take on deadly brain tumors
- New combo attack on recurrent brain tumors shows promise in early trial